Subscribe to Newsletter

Subspecialties

Subspecialties Retina

Awh versus the NEI

| Roisin McGuigan

Are people with certain genotypes actively harmed by AREDS supplementation, accelerating AMD?

Subspecialties Cataract

Feeling the Pressure

| Roisin McGuigan

Can a new implantable microfluidic sensor put IOP tracking in the hands – or rather eyes – of patients with glaucoma?

Subspecialties Cornea / Ocular Surface

CXL Excels

| Roisin McGuigan

Two studies demonstrate the safety and potential of decentered corneal collagen cross linking

Subspecialties Retina

Choroid Cartography

| Mark Hillen

Why are certain regions of the choroid more prone to disease than others? To answer that, you need proteomics

Subspecialties Cataract

IOL Clinical Trials

| Mark Hillen

One of the most commonly performed surgical procedures in the world is cataract surgery

Subspecialties Imaging & Diagnostics

Goodbye LRI, Hello Toric IOL

| Sanjay Mantry

Limbal relaxing incisions were a large part of my approach to treating astigmatism in patients undergoing cataract surgery. No longer…

Subspecialties Imaging & Diagnostics

The Lifelong, Multifaceted Pursuit of Eye Health

| Cécile Delcourt

We look to the oldest in society to understand the contribution of poor nutrition to ophthalmic disease

Subspecialties Basic & Translational Research

Finding Corneal Limbal Stem Cells for Transplantation Could be as Easy as ABCB5

| Roisin McGuigan

Identifying corneal limbal stem cells for transplantation has been a major challenge. But now a highly specific marker of these cells has been found: ABCB5

Subspecialties Retina

A Retinoid a Day Keeps The Blindness Away

| Mark Hillen

Oral replacement therapy of the retinoid intermediate that fails to form in some types of Leber congenital amaurosis shows significant promise in an early-phase clinical trial

Subspecialties Retina

The Retina, Renewed… Thanks to Your Own Skin Cells

| Mark Hillen

Might you soon take a skin cell from a patient with retinitis pigmentosa, roll it back to a pluripotent state, culture it to become retinal cells and trial gene therapy on it in vitro?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: